Yoshito Zamami

3.0k total citations
174 papers, 2.1k citations indexed

About

Yoshito Zamami is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Yoshito Zamami has authored 174 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 32 papers in Cardiology and Cardiovascular Medicine and 32 papers in Oncology. Recurrent topics in Yoshito Zamami's work include Neuropeptides and Animal Physiology (18 papers), Nitric Oxide and Endothelin Effects (14 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (12 papers). Yoshito Zamami is often cited by papers focused on Neuropeptides and Animal Physiology (18 papers), Nitric Oxide and Endothelin Effects (14 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (12 papers). Yoshito Zamami collaborates with scholars based in Japan, United States and Taiwan. Yoshito Zamami's co-authors include Hiromu Kawasaki, Shingo Takatori, Keisuke Ishizawa, Mitsuhiro Goda, Toshihiro Koyama, Takahiro Niimura, Yuki Izawa‐Ishizawa, Yoshihisa Kitamura, Kenshi Takechi and Naoto Okada and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Neurology.

In The Last Decade

Yoshito Zamami

160 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshito Zamami Japan 25 450 401 285 284 266 174 2.1k
Bart A. Ploeger Netherlands 26 630 1.4× 364 0.9× 211 0.7× 166 0.6× 169 0.6× 67 2.3k
Yi Huan China 21 700 1.6× 189 0.5× 244 0.9× 172 0.6× 332 1.2× 68 2.7k
Barbara Rinaldi Italy 26 541 1.2× 154 0.4× 385 1.4× 593 2.1× 311 1.2× 90 2.0k
Francesco Rossi Italy 23 219 0.5× 266 0.7× 145 0.5× 209 0.7× 141 0.5× 112 1.7k
Bikui Zhang China 33 1.1k 2.6× 345 0.9× 252 0.9× 220 0.8× 350 1.3× 166 3.3k
Ping He China 26 585 1.3× 115 0.3× 211 0.7× 409 1.4× 209 0.8× 81 2.3k
Francisco Abad‐Santos Spain 31 527 1.2× 466 1.2× 79 0.3× 314 1.1× 214 0.8× 220 3.3k
Stephan Krähenbühl Switzerland 32 988 2.2× 299 0.7× 222 0.8× 240 0.8× 286 1.1× 100 3.1k
Yuji Kumagai Japan 25 493 1.1× 412 1.0× 192 0.7× 149 0.5× 230 0.9× 127 2.0k
Samuel M. Poloyac United States 36 940 2.1× 245 0.6× 198 0.7× 314 1.1× 157 0.6× 120 3.4k

Countries citing papers authored by Yoshito Zamami

Since Specialization
Citations

This map shows the geographic impact of Yoshito Zamami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshito Zamami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshito Zamami more than expected).

Fields of papers citing papers by Yoshito Zamami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshito Zamami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshito Zamami. The network helps show where Yoshito Zamami may publish in the future.

Co-authorship network of co-authors of Yoshito Zamami

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshito Zamami. A scholar is included among the top collaborators of Yoshito Zamami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshito Zamami. Yoshito Zamami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyata, Kôji, Yuki Izawa‐Ishizawa, Masateru Kondo, et al.. (2024). Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments. Biomedicine & Pharmacotherapy. 179. 117418–117418. 1 indexed citations
2.
Iida, Midori, Kenta Yagi, Mitsuhiro Goda, et al.. (2024). A network-based trans-omics approach for predicting synergistic drug combinations. SHILAP Revista de lepidopterología. 4(1). 154–154. 7 indexed citations
3.
Matsumoto, Jun, Naohiro Iwata, Takahiro Niimura, et al.. (2024). Adverse events of nivolumab plus ipilimumab versus nivolumab plus cabozantinib: a real-world pharmacovigilance study. International Journal of Clinical Pharmacy. 46(3). 745–750. 4 indexed citations
4.
Matsumoto, Jun, Naohiro Iwata, Aya Ozaki, et al.. (2024). A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases. International Journal of Clinical Pharmacy. 46(2). 536–541. 4 indexed citations
6.
Aizawa, Fuka, Hirofumi Hamano, Naoto Okada, et al.. (2024). Assessing the effects of interprofessional education by hospital pharmacists on pharmaceutical students using a self-evaluation scale. Journal of Pharmaceutical Health Care and Sciences. 10(1). 61–61.
7.
8.
Niimura, Takahiro, Mitsuhiro Goda, Kôji Miyata, et al.. (2023). Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination. SHILAP Revista de lepidopterología. 3. 1213771–1213771. 2 indexed citations
9.
Goda, Mitsuhiro, Yuki Izawa‐Ishizawa, Kenta Yagi, et al.. (2023). Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage. Clinical and Translational Science. 16(11). 2369–2381. 4 indexed citations
10.
Hamano, Hirofumi, Takahiro Niimura, Kenta Yagi, et al.. (2023). Structural characterization of the optical isomers esomeprazole and omeprazole using the JADER and FAERS databases. Toxicology and Applied Pharmacology. 475. 116632–116632. 4 indexed citations
11.
Hamano, Hirofumi, Takahiro Niimura, Aya Ozaki, et al.. (2023). Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics. International Journal of Cancer. 153(8). 1472–1476. 8 indexed citations
12.
Matsumoto, Jun, Soichiro Ushio, Toshihiro Koyama, et al.. (2022). Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma. Molecular and Cellular Biochemistry. 478(8). 1779–1790. 1 indexed citations
13.
Chuma, Masayuki, Takahiro Niimura, Yutaka Kondo, et al.. (2022). Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis. Clinical Infectious Diseases. 75(8). 1416–1422. 21 indexed citations
14.
Takechi, Kenshi, Takahiro Niimura, Masayuki Chuma, et al.. (2021). Examination of the antiepileptic effects of valacyclovir using kindling mice― search for novel antiepileptic agents by drug repositioning using a large medical information database. European Journal of Pharmacology. 902. 174099–174099. 2 indexed citations
15.
Hagiwara, Hiromi, Hidekatsu Fukuta, Hiroya Hashimoto, et al.. (2020). A comparison of the safety and effectiveness of prasugrel and clopidogrel in younger population undergoing percutaneous coronary intervention: A retrospective study using a Japanese claims database. Journal of Cardiology. 77(3). 285–291. 1 indexed citations
16.
Koyama, Toshihiro, Hideharu Hagiya, Yoshito Zamami, et al.. (2019). Place of death trends among patients with dementia in Japan: a population-based observational study. Scientific Reports. 9(1). 20235–20235. 16 indexed citations
17.
Okada, Naoto, Momoyo Azuma, Masaki Imanishi, et al.. (2018). Potential Usefulness of Early Potassium Supplementation for Preventing Severe Hypokalemia Induced by Liposomal Amphotericin B in Hematologic Patients: A Retrospective Study. Clinical Therapeutics. 40(2). 252–260. 8 indexed citations
18.
Horinouchi, Yuya, Yasumasa Ikeda, Keijo Fukushima, et al.. (2018). Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis. Scientific Reports. 8(1). 10858–10858. 29 indexed citations
19.
Okada, Naoto, et al.. (2017). Kamishoyosan and Shakuyakukanzoto promote recovery from paclitaxel-induced neurite retraction in PC12 cells. Journal of Pharmaceutical Health Care and Sciences. 3(1). 5 indexed citations
20.
Sato, Shiho, Yoshito Zamami, Toru Imai, et al.. (2017). Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia. Scientific Reports. 7(1). 12683–12683. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026